Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise +64,166 $2.49 $160K 169,402
2024-08-23 ZDRAVESKI ZORAN See Remarks Sale −164,686 $5.78 $952K 4,716
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise · Stock Option (Right to Buy) −54,895 30,105
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise · Stock Option (Right to Buy) −25,000 25,000
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise · Stock Option (Right to Buy) −13,125 21,875
2024-08-23 ZDRAVESKI ZORAN See Remarks Option exercise · Stock Option (Right to Buy) −64,166 365,834
2024-06-12 Woods Keith Director Grant or award · Stock Option (Right to Buy) +47,500 47,500
2024-06-12 Dorton Katina Director Grant or award · Stock Option (Right to Buy) +47,500 47,500
2024-06-12 Klencke Barbara Director Grant or award · Stock Option (Right to Buy) +47,500 47,500
2024-06-12 Gruia Gabriela Director Grant or award · Stock Option (Right to Buy) +47,500 47,500
2024-06-12 Nicholson Garry A Director Grant or award · Stock Option (Right to Buy) +47,500 47,500
2024-06-12 Nicholson Garry A Director Grant or award · Stock Option (Right to Buy) +23,750 23,750
2024-06-12 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +47,500 47,500
2024-06-12 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +47,500 47,500
2024-05-01 Louis Chrystal Chief Medical Officer Grant or award · Stock Option (Right to Buy) +380,000 380,000
2024-04-19 BAKER BROS. ADVISORS LP Director Purchase · Warrants to purchase Common Stock +825,968 $7.13 $5.9M 4,018,678
2024-04-19 BAKER BROS. ADVISORS LP Director Purchase · Warrants to purchase Common Stock +8,851,451 $7.13 $63.1M 43,158,741
2024-04-19 Lynx1 Capital Management LP 10% owner Purchase · Pre-funded Warrant (right to buy) +5,000,000 $7.13 $35.6M 5,000,000
2024-02-01 Amello Jason Chief Financial Officer Grant or award · Stock Option (Right to Buy) +750,000 750,000
2024-01-12 ZDRAVESKI ZORAN See Remarks Grant or award · Stock Option (Right to Buy) +52,500 52,500

Page 3 of 8 · 144 trades